Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for Clinical Improvement in Patients with COVID-19 Pneumonia
IRCT20190804044429N7Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tofacitinib in coronavirus pneumonia, sponsored by Mazandaran University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20190804044429N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N7.